- Published on
Infectious Disease – Anaerobic Infections
• Anaerobic infections are induced by bacteria that necessitate diminished oxygen levels for proliferation.
Anaerobes linked to human diseases are aerotolerant; they can endure, but not proliferate, for up to 72 hours in an oxygen-rich environment.
Anaerobic bacteria inhabit mucosal membranes and are predominant in illnesses originating from mucosal and surrounding areas.
EPIDEMIOLOGY Incidence
Anaerobes comprise up to 10% of blood culture isolates in patients with clinically severe bacteremia. No incidence data exists for anaerobic infections at other sites.
FACTORS OF RISK
• Disruption of the mucosal barrier due to neoplasm, chemotherapy, radiation, neutropenia, graft-versus-host disease, surgical intervention, trauma, inflammatory bowel disease, diverticulitis, and appendicitis • Inadequate dental hygiene • Altered mental state, diminished gag reflex, and impaired swallowing
GENERAL PREVENTION
• Bowel preparation and preoperative antibacterial prophylaxis • Excellent oral hygiene • Aspiration precautions
Pathophysiology
• Translocation of indigenous flora into sterile sites resulting from mucosal membrane disruption • Translocation of oral flora into the lungs due to aspiration • Proliferation of obligate anaerobes during polymicrobial infections caused by reduced oxidation–reduction potential from aerobic organisms • Virulence factors allow anaerobic bacteria to induce abscess formation (e.g., Bacteroides fragilis: capsular polysaccharide), evade host defenses (e.g., Prevotella: IgA proteases), and adhere to cell surfaces
For instance, Porphyromonas gingivalis produces proteases, while Fusobacterium necrophorum generates leukotoxin and endotoxin.
ETIOLOGY
• B. fragilis is the predominant isolated anaerobic Gram-negative bacillus. Other Gram-negative bacteria include Fusobacterium, Prevotella, and Porphyromonas species. Peptostreptococcus species are the predominant Gram-positive cocci, while Clostridia represent the primary Gram-positive rods responsible for disease.
FREQUENTLY CO-OCCURRING CONDITIONS
• Dental infections – Pulpitis – Periapical and dental abscess – Perimandibular space infection • Gingivitis – Periodontitis – Periodontal abscess • Extension of periodontal infection resulting in maxillary sinus osteomyelitis or submandibular space infection • Vincent’s stomatitis (trench mouth) • Ludwig’s angina: Bilateral infection of the sublingual region and submandibular regions
Lemierre Syndrome: Infection of the posterior compartment of the lateral pharyngeal space by F. necrophorum, resulting in suppurative thrombophlebitis of the jugular vein and subsequent metastases, predominantly to the lungs.
• Chronic sinusitis and otitis media • Pleuropulmonary infections – Aspiration pneumonia – Necrotizing pneumonia – Lung abscess – Empyema
• Intra-abdominal infections – Peritonitis – Abscesses – Neutropenic colitis (Typhlitis) • Female genital tract infections – Pelvic inflammatory illness – Pelvic abscess – Septic abortion – Endometritis – Tubo-ovarian abscess – Postoperative infection
– Bacterial vaginosis – Pelvic cellulitis – Amnionitis – Septic thrombosis of pelvic veins • Central nervous system infections
Cerebral abscess, epidural abscess, subdural empyema
Anaerobic meningitis: Uncommon, indicative of shunt infection or parameningeal collection.
• Dermatological and subcutaneous conditions – Necrotizing fasciitis – Gas gangrene – Crepitant cellulitis – Bite injuries – Surgical incisions
– Diabetic foot infections – Pressure ulcers
• Bone and joint – Osteomyelitis and septic arthritis in proximity to affected soft tissue locations • Bacteremia – Resulting from an intra-abdominal, vaginal tract, respiratory tract, or soft tissue infection – B. fragilis is the most prevalent isolate
HISTORY OF DIAGNOSIS
• Abrupt emergence of sensitive, hemorrhaging gums, halitosis, unpleasant taste, fever, and cervical lymphadenopathy - Vincent’s stomatitis (trench mouth) • Pain in the submandibular and/or sublingual regions, trismus, and lateral or posterior displacement of the tongue leading to dysphagia and/or airway obstruction – Ludwig’s angina
• Nasopharyngitis or tonsillar abscess, succeeded 1–2 weeks later by pyrexia, submandibular angle lymphadenopathy, discomfort along the lateral portion of the sternocleidomastoid muscle, and pulmonary metastases.
Lemierre's syndrome
• Weight reduction, thoracic discomfort, or pleuritic pain - Empyema
• Persistent malaise, weight reduction, pyrexia, chills, malodorous sputum, and anemia – Anaerobic pulmonary abscess • Impaired cognitive function, dysphagia, chronic respiratory manifestations, weight reduction, pyrexia, and anemia
Aspiration pneumonia
• Neutropenia, right lower quadrant stomach discomfort, fever, diarrhea – Typhlitis • Lack of progress in the infectious process on an antibiotic regimen devoid of anaerobic activity – Indicative of anaerobes
PHYSICAL EXAMINATION
• Deteriorated dental condition – Prevalence of anaerobic oral microbiota with potential for translocation
• Gas in tissue, crepitus – Infection with gas-producing bacteria • Malodorous discharge • Infection near mucosal surfaces • Tissue necrosis, abscess development – Suggestive of anaerobic organisms DIAGNOSTIC TESTS & INTERPRETATION Laboratory
Anaerobes present significant challenges in cultivation and identification. In numerous instances, the anaerobic origin of an infection remains unverified.
• Cultural methodology
Specimens must be obtained while preventing contamination of the indigenous flora of mucosal surfaces.
- Liquids or tissues are preferred over swab specimens.
Air must be removed from the syringe utilized for aspiration, and the needle must be sealed.
– Utilization of anaerobic transport media. – Expedited processing of samples.
All specimens must undergo Gram staining; the absence of growth in culture alongside the presence of Gram-positive and Gram-negative organisms in Gram staining indicates the potential existence of anaerobic organisms.
Imaging • Radiographs – Presence of air–fluid levels, cavity formation, and gas in tissue • CT and/or MRI scans – Frequently essential for delineating anatomical location and disease extent
Diagnostic Procedures/Other: CT- or ultrasound-guided aspiration or biopsy
DIFFERENTIAL DIAGNOSIS
Anaerobic lung abscesses must be distinguished from mycobacterial infections.
TREATMENT
• The treatment comprises a combination of surgical interventions (resection, debridement, drainage) and antimicrobial therapy. • Antibiotics administered must encompass both aerobic and anaerobic bacteria due to the polymicrobial characteristics of numerous illnesses.
Empirical selection of antibiotic regimen based on infection type, Gram stain results, tissue penetration, and toxicity. Susceptibility testing is challenging because to anaerobic culture methodologies, prolonged turnaround times, and inadequate quality control.
• Susceptibility testing is advised for patients requiring extended antibiotic treatment: cerebral abscess, osteomyelitis, and infections associated with prosthetic devices. • Anaerobic infections originating from below the diaphragm should be managed with targeted therapy against B. fragilis. Members of the B. fragilis group exhibit resistance to penicillin.
Antimicrobial drugs effective against anaerobes include carbapenems, β-lactam/β-lactamase inhibitor combinations, and metronidazole (note that metronidazole is ineffective against Actinomyces spp., Propionibacterium spp., peptostreptococci, and microaerophilic streptococci).
• Rising incidence of antibiotic resistance in B. fragilis.
Resistance to cephamycins is 8–14%, clindamycin 26% and moxifloxacin 38%
CONTINUED MANAGEMENT POST-TREATMENT SUGGESTIONS
Patient Surveillance
Ensure sufficient drainage of abscesses with further imaging.
Surgical resection is warranted if drainage proves ineffective.
• Conduct repeat sampling if the infection does not respond to antimicrobial therapy to assess for drug-resistant organisms.
• Surveillance for antimicrobial drug toxicities.
COMPLICATIONS
Uninterrupted dissemination of untreated illnesses
• Anaerobic infections are induced by bacteria that necessitate diminished oxygen levels for proliferation.
Anaerobes linked to human diseases are aerotolerant; they can endure, but not proliferate, for up to 72 hours in an oxygen-rich environment.
Anaerobic bacteria inhabit mucosal membranes and are predominant in illnesses originating from mucosal and surrounding areas.
EPIDEMIOLOGY Incidence
Anaerobes comprise up to 10% of blood culture isolates in patients with clinically severe bacteremia. No incidence data exists for anaerobic infections at other sites.
FACTORS OF RISK
• Disruption of the mucosal barrier due to neoplasm, chemotherapy, radiation, neutropenia, graft-versus-host disease, surgical intervention, trauma, inflammatory bowel disease, diverticulitis, and appendicitis • Inadequate dental hygiene • Altered mental state, diminished gag reflex, and impaired swallowing
GENERAL PREVENTION
• Bowel preparation and preoperative antibacterial prophylaxis • Excellent oral hygiene • Aspiration precautions
Pathophysiology
• Translocation of indigenous flora into sterile sites resulting from mucosal membrane disruption • Translocation of oral flora into the lungs due to aspiration • Proliferation of obligate anaerobes during polymicrobial infections caused by reduced oxidation–reduction potential from aerobic organisms • Virulence factors allow anaerobic bacteria to induce abscess formation (e.g., Bacteroides fragilis: capsular polysaccharide), evade host defenses (e.g., Prevotella: IgA proteases), and adhere to cell surfaces
For instance, Porphyromonas gingivalis produces proteases, while Fusobacterium necrophorum generates leukotoxin and endotoxin.
ETIOLOGY
• B. fragilis is the predominant isolated anaerobic Gram-negative bacillus. Other Gram-negative bacteria include Fusobacterium, Prevotella, and Porphyromonas species. Peptostreptococcus species are the predominant Gram-positive cocci, while Clostridia represent the primary Gram-positive rods responsible for disease.
FREQUENTLY CO-OCCURRING CONDITIONS
• Dental infections – Pulpitis – Periapical and dental abscess – Perimandibular space infection • Gingivitis – Periodontitis – Periodontal abscess • Extension of periodontal infection resulting in maxillary sinus osteomyelitis or submandibular space infection • Vincent’s stomatitis (trench mouth) • Ludwig’s angina: Bilateral infection of the sublingual region and submandibular regions
Lemierre Syndrome: Infection of the posterior compartment of the lateral pharyngeal space by F. necrophorum, resulting in suppurative thrombophlebitis of the jugular vein and subsequent metastases, predominantly to the lungs.
• Chronic sinusitis and otitis media • Pleuropulmonary infections – Aspiration pneumonia – Necrotizing pneumonia – Lung abscess – Empyema
• Intra-abdominal infections – Peritonitis – Abscesses – Neutropenic colitis (Typhlitis) • Female genital tract infections – Pelvic inflammatory illness – Pelvic abscess – Septic abortion – Endometritis – Tubo-ovarian abscess – Postoperative infection
– Bacterial vaginosis – Pelvic cellulitis – Amnionitis – Septic thrombosis of pelvic veins • Central nervous system infections
Cerebral abscess, epidural abscess, subdural empyema
Anaerobic meningitis: Uncommon, indicative of shunt infection or parameningeal collection.
• Dermatological and subcutaneous conditions – Necrotizing fasciitis – Gas gangrene – Crepitant cellulitis – Bite injuries – Surgical incisions
– Diabetic foot infections – Pressure ulcers
• Bone and joint – Osteomyelitis and septic arthritis in proximity to affected soft tissue locations • Bacteremia – Resulting from an intra-abdominal, vaginal tract, respiratory tract, or soft tissue infection – B. fragilis is the most prevalent isolate
HISTORY OF DIAGNOSIS
• Abrupt emergence of sensitive, hemorrhaging gums, halitosis, unpleasant taste, fever, and cervical lymphadenopathy - Vincent’s stomatitis (trench mouth) • Pain in the submandibular and/or sublingual regions, trismus, and lateral or posterior displacement of the tongue leading to dysphagia and/or airway obstruction – Ludwig’s angina
• Nasopharyngitis or tonsillar abscess, succeeded 1–2 weeks later by pyrexia, submandibular angle lymphadenopathy, discomfort along the lateral portion of the sternocleidomastoid muscle, and pulmonary metastases.
Lemierre's syndrome
• Weight reduction, thoracic discomfort, or pleuritic pain - Empyema
• Persistent malaise, weight reduction, pyrexia, chills, malodorous sputum, and anemia – Anaerobic pulmonary abscess • Impaired cognitive function, dysphagia, chronic respiratory manifestations, weight reduction, pyrexia, and anemia
Aspiration pneumonia
• Neutropenia, right lower quadrant stomach discomfort, fever, diarrhea – Typhlitis • Lack of progress in the infectious process on an antibiotic regimen devoid of anaerobic activity – Indicative of anaerobes
PHYSICAL EXAMINATION
• Deteriorated dental condition – Prevalence of anaerobic oral microbiota with potential for translocation
• Gas in tissue, crepitus – Infection with gas-producing bacteria • Malodorous discharge • Infection near mucosal surfaces • Tissue necrosis, abscess development – Suggestive of anaerobic organisms DIAGNOSTIC TESTS & INTERPRETATION Laboratory
Anaerobes present significant challenges in cultivation and identification. In numerous instances, the anaerobic origin of an infection remains unverified.
• Cultural methodology
Specimens must be obtained while preventing contamination of the indigenous flora of mucosal surfaces.
- Liquids or tissues are preferred over swab specimens.
Air must be removed from the syringe utilized for aspiration, and the needle must be sealed.
– Utilization of anaerobic transport media. – Expedited processing of samples.
All specimens must undergo Gram staining; the absence of growth in culture alongside the presence of Gram-positive and Gram-negative organisms in Gram staining indicates the potential existence of anaerobic organisms.
Imaging • Radiographs – Presence of air–fluid levels, cavity formation, and gas in tissue • CT and/or MRI scans – Frequently essential for delineating anatomical location and disease extent
Diagnostic Procedures/Other: CT- or ultrasound-guided aspiration or biopsy
DIFFERENTIAL DIAGNOSIS
Anaerobic lung abscesses must be distinguished from mycobacterial infections.
TREATMENT
• The treatment comprises a combination of surgical interventions (resection, debridement, drainage) and antimicrobial therapy. • Antibiotics administered must encompass both aerobic and anaerobic bacteria due to the polymicrobial characteristics of numerous illnesses.
Empirical selection of antibiotic regimen based on infection type, Gram stain results, tissue penetration, and toxicity. Susceptibility testing is challenging because to anaerobic culture methodologies, prolonged turnaround times, and inadequate quality control.
• Susceptibility testing is advised for patients requiring extended antibiotic treatment: cerebral abscess, osteomyelitis, and infections associated with prosthetic devices. • Anaerobic infections originating from below the diaphragm should be managed with targeted therapy against B. fragilis. Members of the B. fragilis group exhibit resistance to penicillin.
Antimicrobial drugs effective against anaerobes include carbapenems, β-lactam/β-lactamase inhibitor combinations, and metronidazole (note that metronidazole is ineffective against Actinomyces spp., Propionibacterium spp., peptostreptococci, and microaerophilic streptococci).
• Rising incidence of antibiotic resistance in B. fragilis.
Resistance to cephamycins is 8–14%, clindamycin 26% and moxifloxacin 38%
CONTINUED MANAGEMENT POST-TREATMENT SUGGESTIONS
Patient Surveillance
Ensure sufficient drainage of abscesses with further imaging.
Surgical resection is warranted if drainage proves ineffective.
• Conduct repeat sampling if the infection does not respond to antimicrobial therapy to assess for drug-resistant organisms.
• Surveillance for antimicrobial drug toxicities.
COMPLICATIONS
Uninterrupted dissemination of untreated illnesses
0 Comments
